SoftOx Solutions AS
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing p… Read more
Market Cap & Net Worth: SoftOx Solutions AS (SOFTX)
SoftOx Solutions AS (OL:SOFTX) has a market capitalization of $14.81 Million (Nkr168.76 Million) as of March 19, 2026. Listed on the OL stock exchange, this Norway-based company holds position #27690 globally and #158 in its home market, demonstrating a 0.86% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SoftOx Solutions AS's stock price Nkr0.07 by its total outstanding shares 2390416994 (2.39 Billion).
SoftOx Solutions AS Market Cap History: 2018 to 2026
SoftOx Solutions AS's market capitalization history from 2018 to 2026. Data shows change from $4.72 Billion to $14.81 Million (-54.53% CAGR).
SoftOx Solutions AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SoftOx Solutions AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.37x
SoftOx Solutions AS's market cap is 0.37 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $4.72 Billion | $4.32 Million | -$12.93 Million | 1091.90x | N/A |
| 2019 | $6.42 Billion | $4.10 Million | -$16.34 Million | 1566.18x | N/A |
| 2020 | $14.69 Billion | $9.84 Million | -$37.41 Million | 1492.59x | N/A |
| 2021 | $11.75 Billion | $7.90 Million | -$86.29 Million | 1486.99x | N/A |
| 2022 | $4.89 Billion | $7.11 Million | -$71.14 Million | 687.18x | N/A |
| 2023 | $679.75 Million | $6.98 Million | -$39.45 Million | 97.38x | N/A |
| 2024 | $2.94 Million | $7.91 Million | -$42.94 Million | 0.37x | N/A |
Competitor Companies of SOFTX by Market Capitalization
Companies near SoftOx Solutions AS in the global market cap rankings as of March 19, 2026.
Key companies related to SoftOx Solutions AS by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
SoftOx Solutions AS Historical Marketcap From 2018 to 2026
Between 2018 and today, SoftOx Solutions AS's market cap moved from $4.72 Billion to $ 14.81 Million, with a yearly change of -54.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr14.81 Million | -19.59% |
| 2025 | Nkr18.42 Million | +527.14% |
| 2024 | Nkr2.94 Million | -99.57% |
| 2023 | Nkr679.75 Million | -86.09% |
| 2022 | Nkr4.89 Billion | -58.39% |
| 2021 | Nkr11.75 Billion | -20.00% |
| 2020 | Nkr14.69 Billion | +128.76% |
| 2019 | Nkr6.42 Billion | +36.00% |
| 2018 | Nkr4.72 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of SoftOx Solutions AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.81 Million USD |
| MoneyControl | $14.81 Million USD |
| MarketWatch | $14.81 Million USD |
| marketcap.company | $14.81 Million USD |
| Reuters | $14.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.